The Cernilton Solution

Used successfully for over 40 years in Europe and Asia, Cernilton (sir-nill-tun) is a combination of extracts from the pollen of eight different plants. Discovered in Sweden almost half a century ago, this nonallergenic mixture has proven remarkably effective in the treatment of BPH.
In 1988, a double-blind, placebo-controlled study concluded that Cernilton improved nocturia (excessive urination at night-the principal symptom of BPH) in 68.8 percent of the cases, as opposed to 37.2 percent of the placebo group. In regard to residual urine (urine that remains in the bladder), 54.7 percent of the Cernilton group showed improvement, as compared with only 12.5 percent of the placebo.
A second double-blind, placebo-controlled study, published in 1990, mirrored these results. In it, Cernilton was found to either eliminate or improve nocturia in 60 percent of the BPH patients tested. This compared with 30 percent of the subjects on the placebo. Even more impressive was the improvement in bladder emptying-57 percent of the Cernilton users vs. only 10 percent of the placebo group. All told, 69 percent of the Cernilton patients reported an overall improvement in their BPH symptoms.
Recommended dosage is two tablets three times a day in the first week, then one tablet three times a day. For maximum success, Cernilton should be taken in the early stages of BPH, as studies have shown it to be most effective in that period